Results 201 to 210 of about 1,915,304 (214)
Some of the next articles are maybe not open access.
Bioresorbable vascular scaffold versus everolimus‐eluting stents or drug eluting balloon for the treatment of coronary in‐stent restenosis: 1‐Year follow‐up of a propensity score matching comparison (the BIORESOLVE‐ISR Study)
Catheterization and cardiovascular interventions, 2018 E. Moscarella, A. Tanaka, A. Ielasi, B. Cortese, S. Coscarelli, M. D. De Angelis, D. Piraino, A. Latib, Giulietta Grigis, R. Bianchi, D. Buccheri, P. Calabrò, M. Tespili, Pedro Silva Orrego, A. Colombo, A. Varricchio +15 moresemanticscholar +1 more sourceDrug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations.
EuroIntervention, 2016 T. Naganuma, A. Latib, C. Costopoulos, J. Oreglia, L. Testa, F. de Marco, A. Candreva, A. Chieffo, Charbel Naim, M. Montorfano, F. Bedogni, A. Colombo +11 moresemanticscholar +1 more source